rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Leah Rush Cann

Director

Company insider

Files Form 4 as: Director, Longeveron; Director, Lite Strategy.

In numbers

Trades disclosed
9
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
2
Companies where not an officer
2
First trade
20 Oct 2011
Last trade
19 Aug 2026
Last filed
21 Aug 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
LGVN LongeveronDirector · Biotechnology · last 19 Aug 20260 buys · 0 sells
LITS Lite StrategyDirector · Biotechnology · last 29 Jul 20160 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
19 Aug 2026filed 21 Aug 2026LGVN LongeveronBiotechnologySEC FORM 4 Code A—36,000 at $0.00filing
19 Aug 2026filed 21 Aug 2026LGVN LongeveronBiotechnologySEC FORM 4 Code A—36,000 at $0.00filing
29 Jul 2016filed 1 Aug 2016LITS Lite Strategyoption or derivative · BiotechnologySEC FORM 4 Code A—40,000 at $0.00filing
28 Jul 2015filed 29 Jul 2015LITS Lite Strategyoption or derivative · BiotechnologySEC FORM 4 Code A—20,000 at $0.00filing
14 Jul 2014filed 16 Jul 2014LITS Lite Strategyoption or derivative · BiotechnologySEC FORM 4 Code A—8,000 at $0.00filing
15 Jul 2013filed 17 Jul 2013LITS Lite Strategyoption or derivative · BiotechnologySEC FORM 4 Code A—6,730 at $0.00filing
29 Mar 2013filed 2 Apr 2013LITS Lite Strategyoption or derivative · BiotechnologySEC FORM 4 Code A—4,032 at $0.00filing
21 Sep 2012filed 25 Sep 2012LITS Lite Strategyoption or derivative · BiotechnologySEC FORM 4 Code A—23,810 at $0.00filing
20 Oct 2011filed 24 Oct 2011LITS Lite Strategyoption or derivative · BiotechnologySEC FORM 4 Code A—25,169 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Stephen H. WillardChief Executive Officer · Chief Executive Officer at Longeveron, filing Form 4 there in the last year
Paul T. LehrGeneral Counsel, Secretary · General Counsel, Secretary at Longeveron, filing Form 4 there in the last year
Nataliya AgafonovaChief Medical Officer · Chief Medical Officer at Longeveron, filing Form 4 there in the last year
Nirav S. JhaveriChief Financial Officer · Chief Financial Officer at Longeveron, filing Form 4 there in the last year
Devin BlassCTO & SVP of CMC · CTO & SVP of CMC at Longeveron, filing Form 4 there in the last year